Mar 21, 2026Glp1 AgonistsDo GLP-1 Drugs Raise Cancer Risk? What Trials ShowDo Ozempic, Wegovy, and Mounjaro raise cancer risk? Evidence from 48 trials and 94,245 patients finds no signal within 2–5 years.liraglutideglp-1 agoniststhyroid cancersaxendaRead article →